| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |